26
Feb
#Sovateltide #Pharmazz #StrokeTreatment #Neuropharmacology #CriticalCare #DrugDiscovery #NIPERMohali #ProfAnilGulati #BrainHealth Mohali: In a landmark event highlighting the future of neurotherapeutics, Pharmazz, Inc., a biopharmaceutical company focused on critical care, showcased the discovery and clinical success of its novel stroke treatment drug, Sovateltide, at a two-day workshop organized by the Department of Pharmacology and Toxicology, NIPER, SAS Nagar (Mohali). The workshop, titled “Drug Discovery and Development in New Millennium - 4 (D3NM-4),” brought together leading researchers, students, and pharmaceutical professionals under the theme “Interfacing with Emerging Neuroprotective Strategies & Neuropharmacological Techniques.” Delivering the keynote address was Prof. Anil Gulati, Founder and CEO…
